期刊
GENE THERAPY
卷 17, 期 2, 页码 150-157出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2009.135
关键词
HIV; FIV; episome; zinc-finger nuclease; vaccine
Lentiviral vectors (LVs) offer the advantages of a large packaging capacity, broad cell tropism or specific cell-type targeting through pseudotyping, and long-term expression from integrated gene cassettes. However, transgene integration carries a risk of disrupting gene expression through insertional mutagenesis and may not be required for all applications. A non-integrating LV may be beneficial in cases in which transient gene expression is desired. Several recent publications outline the development and initial biological characterization of such vectors. Here, we discuss the potential applications and new directions for the development of integration-defective LVs. Gene Therapy (2010) 17, 150-157; doi: 10.1038/gt.2009.135; published online 22 October 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据